PPAR is known to be involved in NASH and ASH progression [35,37,39] and MLXIPL (also known as ChREBP) is one of the key regulators in glucose metabolism and is also involved in maintenance of tri glyceride levels [40]. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.